Results with GnRH antagonist protocols are equivalent to GnRH agonist protocols in comparable patient populations

Journal of Reproductive Medicine

Volumn 57, Issue 3-4, 2012, Pages 123-128

  Luna, Martha ^a   Vela, Gerardo ^a   McDonald, Casey A ^a   Copperman, Alan B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Controlled ovarian hyperstimulation; GnRH; GnRH agonist; GnRH antagonist; In vitro fertilization; Ovarian stimulation; Ovulation induction

Indexed keywords

GANIRELIX; LEUPRORELIN; DRUG DERIVATIVE; FERTILITY PROMOTING AGENT; GONADORELIN;

ADULT; ARTICLE; DOWN REGULATION; DRUG DOSE REDUCTION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; NIDATION; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CASE CONTROL STUDY; DRUG ADMINISTRATION; DRUG POTENTIATION; INTRAMUSCULAR DRUG ADMINISTRATION; METHODOLOGY; OVULATION INDUCTION; STATISTICS; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; EMBRYO TRANSFER; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INJECTIONS, INTRAMUSCULAR; NEW YORK CITY; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84860812855     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cousineau TM, Domar AD: Psychological impact of infertility. Best Pract Res Clin Obstet Gynaecol 2007;21:293-308
2. Verberg MG, Eijkemans MJ, Heijnen EM, et al: Why do some couples drop out of IVF treatment? A prospective cohort study. Hum Reprod 2008;23:2050-2055
3. Brandes M, van der Steen JOM, Bokdam SB, et al: When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population. Hum Reprod 2009;24:3127-3135
4. de Klerk C, Heijnen EM, Macklon NS, et al: The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF. Hum Reprod 2006;21:721-727
5. Flisser E, Scott RT Jr, Copperman AB: Patient friendly IVF: How should it be defined? Fertil Steril 2007;88:547-549
6. Flisser E, Copperman AB: Why do couples drop-out from IVF treatment? Hum Reprod 2009;24:758-759
7. Edwards RG, Lobo R, Bouchard P: Time to revolutionize ovarian stimulation. Hum Reprod 1996;11:917-919
8. Janssens RM, Lambalk CB, Vermeiden JP, et al: Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: A prospective, randomized, double-blind, placebo-controlled study. Hum Reprod 2000;15:2333-2340
9. Huirne JA, Homburg, R, Lambalk CB: Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod 2007;22:2805-2813
10. Reissmann T, Schally AV, Bouchard P, et al: The LHRH antagonist cetrorelix: A review. Hum Reprod Update 2000;6: 322-331
11. Al-Anany H, Aboulghar M: GnRH antagonists for assisted reproduction: A Cocharane review. Hum Reprod 2002;17: 874-885
12. Devaux A, Pouly JL, Bachelot A, et al: Biological effects of GnRH antagonists. Gynecol Obstet Fertil 2004;32:741-747
13. Griesinger G, Felberbaum R, Diedrich K: GnRH antagonists in ovarian stimulation: A treatment regimen of clinicians' second choice? Data from the German national IVF registry. Hum Reprod 2005;20:2373-2375
14. Al-Inany HG, Abou-Setta AM, Aboulghar M: Gonadotropinreleasing hormone antagonists for assisted conception: A Cochrane review. Reprod Biomed Online 2007;14:640-649
15. Moraloglu O, Klic S, Karyalcin R, et al: Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients. Adv Ther 2008;25:266-273
16. Borm G, Mannaerts B: Treatment with the gonadotrophinreleasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 2000;15:1490-1498. Erratum in Hum Reprod 2000;15:1877
17. Albano C, Felderbaum RE, Smitz J: Ovarian stimulation with HMG: Results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRHagonist buserelin. Hum Reprod 2000;15:526-531
18. Tariatzis B, Fauser B, Kollibianakis E, et al: GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 2006;12:333-340
19. Copperman AB: Antagonists in poor responders. Fertil Steril 2003;80:S16-24
20. Kolibianakis EM, Papanikolau EG, Camus M, et al: Effect of oral contraceptive pill treatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF: A randomized controlled trial. Hum Reprod 2006;21:352-357
21. Shapiro D, Carter M, Mitchell-Leef D, et al: Plateau or drop in estradiol (E2) on the day after initiation of the GnRH antagonist AntagonTM in in vitro fertilization (IVF) treatment cycles does not affect pregnancy outcome. Fertil Steril 2002; 78(Suppl 1):S22
22. Griesinger G, Diedrich K, Tarlatzis BC, et al: GnRH antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: A meta-analysis. Reprod Biomed Online 2006;13:628-638
23. Bellver J, Albert C, Labarta E, et al: Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill treatment. Fertil Steril 2007;87:1098-1101
24. Smulders B, van Oirschot SM, Farquhar C, et al: Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database Syst Rev 2010 Jan 20;(1):CD006109
25. Bonduelle M, Oberye J, Mannaerts B, et al: Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation. Hum Reprod 2010;25:1433-1440